Over the past three decades, meaningful progress has been made in the research and understanding of cystic fibrosis (CF). 1 ...

Vertex Pharmaceuticals ended a Phase 1/2 study of an inhaled cystic fibrosis treatment developed jointly with Moderna after the study showed "persistent tolerability issues" with the drug. The ...

Vertex Pharmaceuticals halted a cystic fibrosis program in the works with Moderna over lung inflammation concerns. The ...

Vertex Pharmaceuticals on Monday ⁠beat ⁠Wall Street estimates for ⁠first-quarter adjusted profit, helped by a near eight-fold ...

Maren Denison, third-year student at the University of Iowa, was in sixth grade when she found out her lung function had dropped to 60 percent as half of her lung had collapsed and was scarred shut.

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung function ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and ...

Your body constantly renews your bone tissue in a process called bone turnover or bone remodeling. This process involves resorption (breaking down bone) and then reforming it. In people with cystic ...

Oklahoma family shares journey with cystic fibrosis ahead of awareness walk ...

From overcoming hospital stays as a newborn to advocating in D.C.: Discover how Rachel’s resilience and the CF community ...